Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,514
datasets available to search
ShareScore release 0.9.0
Dataset results
3,514 results for “cell therapy”
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00480025. IPD Sharing: YES. Countries: 34. Publications: 3.
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epi
ClinicalTrials.gov study NCT04538664. IPD Sharing: YES. Countries: 26. Publications: 3.
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02186847. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01459497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00703820. IPD Sharing: Not stated. Countries: 2. Publications: 2.
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia
ClinicalTrials.gov study NCT00125788. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00326599. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy
ClinicalTrials.gov study NCT01646021. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00874848. IPD Sharing: NO. Countries: 2. Publications: 1.
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00004859. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
ClinicalTrials.gov study NCT04148430. IPD Sharing: YES. Countries: 1. Publications: 1.
SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
ClinicalTrials.gov study NCT00083889. IPD Sharing: Not stated. Countries: 11. Publications: 6.
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
ClinicalTrials.gov study NCT03703375. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy
ClinicalTrials.gov study NCT00738530. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
ClinicalTrials.gov study NCT00678392. IPD Sharing: YES. Countries: 22. Publications: 11.
Bone Tissue Engineering Using Autologous Bone Repair Cell (BRC) Therapy for Sinus Floor Bone Augmentation
ClinicalTrials.gov study NCT00980278. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
ClinicalTrials.gov study NCT01800058. IPD Sharing: Not stated. Countries: 1. Publications: 22.
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00203931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT03068819. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.